CN105079571A - Medicinal preparation for treating senility lung infection - Google Patents

Medicinal preparation for treating senility lung infection Download PDF

Info

Publication number
CN105079571A
CN105079571A CN201510601535.9A CN201510601535A CN105079571A CN 105079571 A CN105079571 A CN 105079571A CN 201510601535 A CN201510601535 A CN 201510601535A CN 105079571 A CN105079571 A CN 105079571A
Authority
CN
China
Prior art keywords
parts
treatment
person
radix
old age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510601535.9A
Other languages
Chinese (zh)
Inventor
赵明亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Original Assignee
Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Zhengliang Pharmaceutical Technology Co Ltd filed Critical Nanjing Zhengliang Pharmaceutical Technology Co Ltd
Priority to CN201510601535.9A priority Critical patent/CN105079571A/en
Publication of CN105079571A publication Critical patent/CN105079571A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of Chinese herbal preparations, and particularly provides a medicinal preparation for treating senility lung infection. The medicinal preparation is prepared from the following raw materials in parts by weight: 30 parts of ciliatenerve knotweed root, 15 parts of tubeflower viburnum herb, 18 parts of eucheuma, 25 parts of herb or root of common rockvine, 18 parts of fritillaria thun-bergli, 18 parts of trichosanthes peel, 15 parts of lotus leaves, 20 parts of lily, 25 parts of rhizoma anemarrhenae, 20 parts of lophatherum gracile, 25 parts of adenophora tetraphylla, 20 parts of honeysuckle flowers, 15 parts of pinellia ternata, 15 parts of dried tangerine or orange peel, 15 parts of apricot kernels, 25 parts of rehmannia, 15 parts of bark of mangnolia officinalis, and 5 parts of licorice root. The medicinal preparation can treat senility lung infection.

Description

A kind of pharmaceutical preparation being used for the treatment of person in middle and old age's pulmonary infection
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to a kind ofly be used for the treatment of pharmaceutical preparation of person in middle and old age's pulmonary infection and its preparation method and application.
Background technology
Pneumonia is the most common with bacterial infection, is secondly virus and mycoplasma, chlamydia infection.Have investigation display, over-65s senile pneumonia sickness rate is youthful 5.4 times, and overall mortality rate, up to more than 30%, is youthful 6.2 times.Pneumonia has become the 4th the lethal cause of disease of over-65s old people, is the first cause of the death of more than 80 years old aged.For this reason, the needs that the medicine developing the more person in middle and old age for the treatment of safely and effectively pulmonary infections meets clinical treatment are bursting to.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of person in middle and old age's pulmonary infection disease.In order to reach this object, adopt following technical scheme:
Technical scheme: a kind of pharmaceutical preparation being used for the treatment of person in middle and old age's pulmonary infection, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Radix Polygoni Ciliinerve 30 parts, Folium Viburni Cylindrici 15 parts, Eucheuma muricatum (Gmel.) Web.Van Bos. 18 parts, Herba Seu Radix Tetrastigmatis Obtecti 25 parts, Bulbus Fritillariae Uninbracteatae 18 parts, Pericarpium Trichosanthis 18 parts, 15 parts, Folium Nelumbinis, Bulbus Lilii 20 parts, the Rhizoma Anemarrhenae 25 parts, Herba Lophatheri 20 parts, Radix Adenophorae 25 parts, Flos Lonicerae 20 parts, the Rhizoma Pinelliae 15 parts, Pericarpium Citri Reticulatae 15 parts, 15 parts, Semen Armeniacae Amarum, Radix Rehmanniae 25 parts, Cortex Magnoliae Officinalis 15 parts, 5 parts, Radix Glycyrrhizae.
The described pharmaceutical preparation being used for the treatment of person in middle and old age's pulmonary infection, dosage form is pharmaceutically acceptable granule, tablet, capsule.
The described pharmaceutical preparation being used for the treatment of person in middle and old age's pulmonary infection, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
The described application of pharmaceutical preparation in preparation treatment person in middle and old age lung infection medicine being used for the treatment of person in middle and old age's pulmonary infection.
Radix Polygoni Ciliinerve is Polygonaceae Pteroxygonum plant Pteroxygonum giraldii PteroxygonumgiraldiiDamm.etDiels, is used as medicine with tuber.Autumn excavates, removing stem and leaf and fibrous root, and clean section is dried: heat clearing away, removing toxic substances, hemostasis, pain relieving.For enteritis, dysentery, lumbago and skelalgia, has blood in stool, metrorrhagia; Burn and scald is controlled in external, furuncle, lyssodexis.
Folium Viburni Cylindrici be Radix Ophiopogonis Piao's vegetation water redwood leaf or root, flower.Clearing away heat and cooling blood, removing dampness dredging collateral.Control cough caused by dryness, dysentery, rheumatalgia, traumatic injury, skin infection scabies.
Eucheuma muricatum (Gmel.) Web.Van Bos. is the frond of Hong Ling dish section plant Eucheuma muricatum (Gmel.) Web.Van Bos. or Margarita Eucheuma muricatum (Gmel.) Web.Van Bos..Expectorant.Can be reduced phlegm knot, mass in the abdomen, hemorrhoid poison.
Herba Seu Radix Tetrastigmatis Obtecti is that rattan Tetrastigmaobtectum (Wall.exLaws.) Planch. is climbed on Vitaceae Tetrastigma plant precipice, is used as medicine with Herb.The whole year can adopt, and dries for subsequent use or using fresh herb.Dispel the wind, dehumidifying, promoting the circulation of blood, detoxicating functions, can control headache, general pain, rheumatic arthralgia, multiple abscess, sore.All the other Chinese medicines are pharmacopeia kind.
Beneficial effect: the traditional Chinese medical science is thought, person in middle and old age's pulmonary infection mostly is stagnation of QI due to depression of the liver, weakness of the spleen and stomach is done, Radix Polygoni Ciliinerve of the present invention, Folium Viburni Cylindrici, Eucheuma muricatum (Gmel.) Web.Van Bos., Herba Seu Radix Tetrastigmatis Obtecti, Bulbus Fritillariae Uninbracteatae, Pericarpium Trichosanthis, Folium Nelumbinis nourishing lung yin are monarch drug, and Bulbus Lilii, the Rhizoma Anemarrhenae, Herba Lophatheri, Radix Adenophorae, Flos Lonicerae, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Semen Armeniacae Amarum, Radix Rehmanniae, Cortex Magnoliae Officinalis warming yang for resolving fluid retention are ministerial drug, and Radix Glycyrrhizae is adjuvant, the mutual compatibility of full side, nourish lung yin, air making-up and spleen enlivening, warming yang for resolving fluid retention, treatment person in middle and old age pulmonary infection successful.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, the preparation of granule embodiment: get Radix Polygoni Ciliinerve 30g, Folium Viburni Cylindrici 15g, Eucheuma muricatum (Gmel.) Web.Van Bos. 18g, Herba Seu Radix Tetrastigmatis Obtecti 25g, Bulbus Fritillariae Uninbracteatae 18g, Pericarpium Trichosanthis 18g, Folium Nelumbinis 15g, Bulbus Lilii 20g, Rhizoma Anemarrhenae 25g, Herba Lophatheri 20g, Radix Adenophorae 25g, Flos Lonicerae 20g, Rhizoma Pinelliae 15g, Pericarpium Citri Reticulatae 15g, Semen Armeniacae Amarum 15g, Radix Rehmanniae 25g, Cortex Magnoliae Officinalis 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, and atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, make granule.
2, the preparation of Tablets Example: get Radix Polygoni Ciliinerve 30g, Folium Viburni Cylindrici 15g, Eucheuma muricatum (Gmel.) Web.Van Bos. 18g, Herba Seu Radix Tetrastigmatis Obtecti 25g, Bulbus Fritillariae Uninbracteatae 18g, Pericarpium Trichosanthis 18g, Folium Nelumbinis 15g, Bulbus Lilii 20g, Rhizoma Anemarrhenae 25g, Herba Lophatheri 20g, Radix Adenophorae 25g, Flos Lonicerae 20g, Rhizoma Pinelliae 15g, Pericarpium Citri Reticulatae 15g, Semen Armeniacae Amarum 15g, Radix Rehmanniae 25g, Cortex Magnoliae Officinalis 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds dextrin 50g, granulates, tabletting, makes tablet.
3, the preparation of capsule embodiment: get Radix Polygoni Ciliinerve 30g, Folium Viburni Cylindrici 15g, Eucheuma muricatum (Gmel.) Web.Van Bos. 18g, Herba Seu Radix Tetrastigmatis Obtecti 25g, Bulbus Fritillariae Uninbracteatae 18g, Pericarpium Trichosanthis 18g, Folium Nelumbinis 15g, Bulbus Lilii 20g, Rhizoma Anemarrhenae 25g, Herba Lophatheri 20g, Radix Adenophorae 25g, Flos Lonicerae 20g, Rhizoma Pinelliae 15g, Pericarpium Citri Reticulatae 15g, Semen Armeniacae Amarum 15g, Radix Rehmanniae 25g, Cortex Magnoliae Officinalis 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds starch 50g, granulates, fill, makes capsule.
4, pharmaceutical preparation treatment person in middle and old age pulmonary infection of the present invention clinical research
4.1 general data: this pharmaceutical preparation is applied to clinical observation person in middle and old age pulmonary infection case 50 example, 62 ~ 75 years old age.The shortest person of the course of disease 4 months, most elder reaches 1 year.
4.2 diagnostic criterias: (1), how without classical symptoms such as generating heat, cough up phlegm, has symptom only to account for 35%.(2) starting disease to be accelerated and dyspnea person accounts for 56% for breathing, or sicken for consciousness, drowsiness, dehydration, loss of appetite etc., asymptomatic person accounts for 10%.(3) sign: rapid pulse can be occurred, breathe fast, chest auscultation audible and moist rale, or with diminished breath sound and bronchovesicular breathing sound.(4) blood test: blood routine examination total white blood cells can increase or not high, but the inflammation performance such as Visible Core more than half moves to left, c reactive protein positive, erythrocyte sedimentation rate is fast.(5) arterial blood gas analysis: can occur that art pO2 declines, but when merging chronic obstructive pulmonary disease, because the bad partial pressure of carbon dioxide of alveolar ventilation raises.(6) C-XF is that bronchopneumonia form person is more common than lobar pneumonia.(7) easily there is water and rock-soil coupling in Pneumonia in Older Patients, acidosis.Because concurrent chronic disease patient is many, easily MOFE occurs, mortality rate is high.
4.3 test methods: prepare clinical sample by above-mentioned process for producing granula, specification is 10 grams every bag, within five days, is a course for the treatment of, one day three bags, take point early, middle and late three half an hour ante cibum.Period in a medicine is avoided eating anything raw or cold, pungent, stimulate and rotten thing.Blank group oral placebo granule five days is a course for the treatment of, one day three bags, point early, middle and late three half an hour ante cibum take.
4.4 criterions of therapeutical effect: recovery from illness: symptom all disappears; Effective: symptom obviously alleviates; Invalid: without significant change or deterioration before and after treatment.
4.5 therapeutic effect: in table 1.
Table 1 liang group comparitive study
Group n Recovery from illness Effectively Invalid Total effective rate (%)
Treatment group 25 7 14 4 84
Blank group 25 0 1 24 4
Visible, the medicine that the present invention obtains can safe and effective treatment person in middle and old age pulmonary infection, and has no side effect.

Claims (4)

1. one kind is used for the treatment of the pharmaceutical preparation of person in middle and old age's pulmonary infection, it is characterized in that, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Radix Polygoni Ciliinerve 30 parts, Folium Viburni Cylindrici 15 parts, Eucheuma muricatum (Gmel.) Web.Van Bos. 18 parts, Herba Seu Radix Tetrastigmatis Obtecti 25 parts, Bulbus Fritillariae Uninbracteatae 18 parts, Pericarpium Trichosanthis 18 parts, 15 parts, Folium Nelumbinis, Bulbus Lilii 20 parts, the Rhizoma Anemarrhenae 25 parts, Herba Lophatheri 20 parts, Radix Adenophorae 25 parts, Flos Lonicerae 20 parts, the Rhizoma Pinelliae 15 parts, Pericarpium Citri Reticulatae 15 parts, 15 parts, Semen Armeniacae Amarum, Radix Rehmanniae 25 parts, Cortex Magnoliae Officinalis 15 parts, 5 parts, Radix Glycyrrhizae.
2. be used for the treatment of the pharmaceutical preparation of person in middle and old age's pulmonary infection as claimed in claim 1, it is characterized in that, dosage form is pharmaceutically acceptable granule, tablet, capsule.
3. be used for the treatment of the pharmaceutical preparation of person in middle and old age's pulmonary infection as claimed in claim 1, it is characterized in that, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
4. the application of the pharmaceutical preparation being used for the treatment of person in middle and old age's pulmonary infection according to claim 1 in the treatment in Aged Patients With Lung infection medicine.
CN201510601535.9A 2015-09-19 2015-09-19 Medicinal preparation for treating senility lung infection Pending CN105079571A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510601535.9A CN105079571A (en) 2015-09-19 2015-09-19 Medicinal preparation for treating senility lung infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510601535.9A CN105079571A (en) 2015-09-19 2015-09-19 Medicinal preparation for treating senility lung infection

Publications (1)

Publication Number Publication Date
CN105079571A true CN105079571A (en) 2015-11-25

Family

ID=54561490

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510601535.9A Pending CN105079571A (en) 2015-09-19 2015-09-19 Medicinal preparation for treating senility lung infection

Country Status (1)

Country Link
CN (1) CN105079571A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104225201A (en) * 2014-10-13 2014-12-24 陈红 Medicinal composition for treating cough

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104225201A (en) * 2014-10-13 2014-12-24 陈红 Medicinal composition for treating cough

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
唐旭东 等: "《老年常见病验方妙用》", 30 April 2010, 科学技术文献出版社 *
姚魁武等: "中医药治疗老年人肺炎临床研究现状", 《河南中医》 *
杨戈等: "中医药治疗老年人肺炎的临床与实验研究", 《中医药学刊》 *

Similar Documents

Publication Publication Date Title
CN102225138B (en) Traditional Chinese medicine composition for treating fracture and preparation method and application thereof
CN104800505A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN103656122B (en) Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof
CN105055924A (en) Medicine preparation used for treating migraine
CN105012587A (en) Medicinal preparation for treating epilepsy
CN105079571A (en) Medicinal preparation for treating senility lung infection
CN105288285A (en) Medicinal preparation for treating chronic bronchitis
CN105055845A (en) Medicine preparation for treating cardiac insufficiency
CN105148078A (en) Medicinal preparation used for treating oral ulcers
CN105106794A (en) Pharmaceutic preparation for treating cough
CN105055786A (en) Medicinal preparation for treating cough
CN105106646A (en) Medicinal preparation for treating chronic pharyngitis
CN105250931A (en) Pharmaceutic preparation for treating stenocardia
CN105596581A (en) Pharmaceutical preparation for treating human papilloma virus infection and preparation method and application of pharmaceutical preparation
CN105169064A (en) Medicinal preparation for whitening skin
CN104922343A (en) Medicinal preparation for treating tinnitus
CN105106602A (en) Pharmaceutical preparation for treating periodontitis
CN104873879A (en) Medicinal preparation for treating insomnia
CN105106764A (en) Medicinal preparation for treating vomitus gravidarum
CN104800497A (en) Traditional Chinese medicine composition for treating irregular menstruation of gynecology
CN105079394A (en) Pharmaceutic preparation for treating arrhythmia
CN105055977A (en) Pharmaceutical preparation for treating chronic cough in children
CN105079674A (en) Medicinal preparation for treating chest stuffiness and pains
CN105106752A (en) Acne removing drug
CN101966270A (en) Traditional Chinese medicinal preparation for treating asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151125